Status:
COMPLETED
Depakote ER in Borderline Personality Disorder
Lead Sponsor:
University of Minnesota
Collaborating Sponsors:
Abbott
Schulz, S. Charles, M.D.
Conditions:
Borderline Personality Disorder
Eligibility:
All Genders
21-55 years
Phase:
NA
Brief Summary
This study examines the effect of Depakote ER versus placebo in a randomized trial of borderline personality disorder. Patients all participate in DBT therapy and those who are not responsive are assi...
Eligibility Criteria
Inclusion
- Male or female patients with the diagnosis of borderline personality disorder between the ages of 21 adn 55 years old. Must be in good physical health -
Exclusion
- Major psychiatric illness on Axis I - schizophrenia or bipolar disorder. May not have current MDD. May not be dependent on illicit substances or alcohol.
- \-
Key Trial Info
Start Date :
March 1 2003
Trial Type :
INTERVENTIONAL
End Date :
September 1 2005
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT00222482
Start Date
March 1 2003
End Date
September 1 2005
Last Update
August 9 2007
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.